Tetrabenazine, a vesicular monoamine transporter 2 inhibitor, inhibits vesicular storage capacity and release of monoamine transmitters in mouse brain tissue
British Journal of Pharmacology · 2024
DOI: 10.1111/bph.17348 ↗Kurz gefasst
Fachartikel in der Zeitschrift British Journal of Pharmacology, 2024. Verfasst von Pál Tod und 6 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Molecular Pharmacology, HUN-REN Institute of Experimental Medicine, Budapest, Hungary. Hauptthemen laut MEDLINE: Tetrabenazine, Vesicular Monoamine Transport Proteins. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Recovery and Resilience Facility of the European Union within the framework of Programme Széchenyi Plan Plus.
Abstract (Originalsprache)
Background and Purpose Tetrabenazine (TBZ), used for treating hyperkinetic disorders, inhibits vesicular monoamine transporter‐2 (VMAT‐2), which sequesters monoamines into vesicles for exocytosis. However, our knowledge of the effect of TBZ on monoaminergic transmission is limited. Herein, we provide neurochemical evidence regarding the effect of VMAT‐2 inhibition on vesicular neurotransmitter release from the prefrontal cortex (PFC) and striatum (STR) (brain regions involved in characteristic TBZ treatment side effects). The interaction between TBZ and MDMA was also assessed regarding motor behaviour in mice. Experimental Approach Vesicular storage capacity and release of [ 3 H]‐noradrenaline ([ 3 H]‐NA), [ 3 H]‐dopamine ([ 3 H]‐DA), [ 3 H]‐serotonin ([ 3 H]‐5‐HT), and [ 3 H]‐acetylcholine ([ 3 H]‐ACh) was studied in mouse PFC and STR ex vivo slice preparations using electrical field stimulation. Additionally, locomotor activity was assessed in vehicle‐treated mice and compared with that of MDMA, TBZ, and co‐administered animals (n = 6) using the LABORAS system. Key Results TBZ lowered the storage capacity and inhibited the vesicular release of [ 3 H]‐NA and [ 3 H]‐DA from the PFC, and [ 3 H]‐DA and [ 3 H]‐5‐HT from the STR in a concentration‐dependent manner. Unlike vesamicol (vesicular ACh uptake inhibitor), TBZ failed to inhibit the vesicular release of [ 3 H]‐ACh from the PFC. When the vesicular storage of the investigated monoamines was inhibited by TBZ in the PFC and STR, MDMA induced the release of transmitters through transporter reversal; MDMA dose dependently increased locomotor activity in vivo. Conclusion and Implications Our observations provide neurochemical evidence explaining the mechanism of VMAT‐2 inhibitors in the brain and support the involvement of dopaminergic and noradrenergic transmission in hyperkinetic movement disorders.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Molecular Pharmacology, HUN-REN Institute of Experimental Medicine, Budapest, Hungary.
- Pharmacology and Drug Safety Research, Gedeon Richter Plc, Budapest, Hungary.
- Department of Pharmacology and Pharmacotherapy, Semmelweis University, Budapest, Hungary.
ORCID-Profile: Pál Tod, Anita Varga, Viktor Román, Balázs Lendvai, Roland Pálkovács, Beáta Sperlágh, E Sylvester Vizi
Förderung
- Recovery and Resilience Facility of the European Union within the framework of Programme Széchenyi Plan Plus
Zitieren
APA
Tod, P., Varga, A., Román, V., Lendvai, B., Pálkovács, R., Sperlágh, B., & Vizi, E. S. (2024). Tetrabenazine, a vesicular monoamine transporter 2 inhibitor, inhibits vesicular storage capacity and release of monoamine transmitters in mouse brain tissue. British Journal of Pharmacology. https://doi.org/10.1111/bph.17348
Vancouver
Tod P, Varga A, Román V, Lendvai B, Pálkovács R, Sperlágh B, et al. Tetrabenazine, a vesicular monoamine transporter 2 inhibitor, inhibits vesicular storage capacity and release of monoamine transmitters in mouse brain tissue. British Journal of Pharmacology. 2024. doi:10.1111/bph.17348
BibTeX
@article{Tod2024,
author = {Tod, Pál and Varga, Anita and Román, Viktor and Lendvai, Balázs and Pálkovács, Roland and Sperlágh, Beáta and Vizi, E Sylvester},
title = {Tetrabenazine, a vesicular monoamine transporter 2 inhibitor, inhibits vesicular storage capacity and release of monoamine transmitters in mouse brain tissue},
journal = {British Journal of Pharmacology},
year = {2024},
doi = {10.1111/bph.17348}
}
EUVIMED